What is the recommended sedation approach for an average adult without significant comorbidities undergoing endoscopic retrograde cholangiopancreatography (ERCP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sedation for ERCP in Average-Risk Adults

Propofol-based monitored anesthesia care (MAC) administered by an anesthesiologist is the recommended sedation approach for average-risk adults undergoing ERCP, using target-controlled infusion with plasma concentrations of 1.0-2.0 µg/mL combined with fentanyl 50-100 µg for analgesia. 1, 2

Primary Sedation Strategy

Propofol-Based MAC (Preferred Approach)

For average-risk patients (ASA class I-II), propofol sedation administered by trained personnel provides safe, effective sedation with high procedural success rates and superior patient satisfaction compared to traditional benzodiazepine/opioid combinations. 3, 1

  • Target-controlled infusion (TCI) of propofol at plasma concentrations of 1.0-2.0 µg/mL provides optimal sedation control with rapid titration capability. 1, 2
  • Total propofol exposure typically ranges 70-350 mg for a standard ERCP procedure (mean approximately 200-465 mg depending on procedural complexity). 1, 2, 4
  • Add fentanyl 50-100 µg as a bolus for analgesia, since propofol has no intrinsic analgesic properties. 1, 5, 2

Administration Personnel

Propofol for ERCP should be administered by an anesthesiologist or trained non-anesthesiologist personnel following established protocols, with the safety profile of non-anesthesiologist-administered propofol (NAAP) being equivalent to standard sedation for low-risk patients. 3, 4

  • The worldwide safety experience with NAAP exceeds 460,000 patients, with extraordinarily low rates of serious adverse events in ASA class I-II patients. 3
  • For ERCP specifically, NAAP appears equivalent in safety to standard sedation, though the experience base is smaller than for routine endoscopy. 3
  • NAAP is more cost-effective than standard sedation for ERCP and improves practice efficiency. 3

Essential Monitoring Requirements

Continuous monitoring of heart rate, blood pressure, and pulse oximetry is mandatory throughout propofol administration, with supplemental oxygen provided to all patients. 1, 5

  • Processed EEG monitoring (BIS or Entropy) targeting BIS 40-60 is mandatory when using target-controlled infusion to prevent both awareness and excessive anesthetic depth. 6
  • Transient oxygen desaturation (SpO₂ <90%) occurs in approximately 5-8% of cases, typically lasting 16-56 seconds and self-limiting. 1, 5

When to Consider General Anesthesia Instead

General endotracheal anesthesia (GEA) should be strongly considered for high-risk patients rather than MAC, as it significantly reduces sedation-related adverse events. 7, 8

High-Risk Criteria Requiring GEA:

  • STOP-BANG score ≥3 (obstructive sleep apnea risk) 7
  • Body mass index ≥35 7
  • ASA class >III 7
  • Mallampati class 4 airway 7
  • Abdominal ascites or chronic lung disease 7

In high-risk patients, GEA reduces composite sedation-related adverse events from 51.5% with MAC to 9.9% with GEA, primarily by eliminating the need for repeated airway maneuvers. 7

Even in average-risk patients (ASA ≤III), GEA reduces sedation-related adverse events from 35% with MAC to 9% with GEA, without prolonging procedure time or affecting success rates. 8

Critical Safety Considerations

Dosing Pitfalls to Avoid

Never administer propofol as bolus dosing during maintenance phase, as this causes hemodynamic instability. 6

Do not exceed effect-site concentrations of 1.5 µg/mL during conscious sedation, as this dramatically increases oversedation and hypoventilation risk, especially with concurrent opioids. 6

Propofol infusion rates of 10 mg/kg/h (≈167 µg/kg/min) produce markedly greater respiratory depression with higher apnea incidence—these rates are inappropriate for ERCP sedation. 5

Respiratory Management

Brief apnea episodes (1-37 seconds) may occur but are typically self-limited; bag-mask ventilation should be immediately available. 3, 1

The need for airway intervention is greater during ERCP than colonoscopy due to the prone/semi-prone positioning and procedural complexity. 3

Recovery Profile

Due to propofol's rapid offset, the majority of patients achieve full recovery (Aldrete score ≥12) within 1 minute after procedure completion, with mean discharge time of approximately 31 minutes. 1, 2

Alternative: Traditional Conscious Sedation

Traditional conscious sedation with midazolam and opioids is generally well-tolerated but has significant limitations, with 14% of ERCPs being poorly tolerated, leading to procedural failure. 1

  • ERCP complexity often necessitates higher benzodiazepine doses than routine endoscopy, with 33% of patients requiring >5.5 mg midazolam and 8% requiring naloxone reversal. 1
  • Most ERCP services in Western Europe and North America have transitioned to propofol-based sedation as standard practice due to superior outcomes. 1

Cost-Effectiveness Considerations

NAAP is more cost-effective than standard sedation for ERCP, while anesthesiologist-administered sedation costs $150-$1500+ more per case depending on local conditions. 3

However, the improved procedural success, patient satisfaction, and reduced complications with propofol-based techniques justify the additional cost in most clinical settings. 3, 1

References

Guideline

Anesthetic Considerations for ERCP

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Safety of non-anaesthesiologist-administered propofol sedation in ERCP.

Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology, 2014

Guideline

Propofol Dosing and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Target-Controlled Infusion Anesthesia Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.